Selective A3 adenosine receptor agonist protects against doxorubicin-induced cardiotoxicity.

about

Cardiac safety profile of patients receiving high cumulative doses of pegylated-liposomal doxorubicin: use of left ventricular ejection fraction is of unproven value.

P2860

Q48151662-4856EB76-B8E0-4C14-AE23-34DF5056D843

P2860

Selective A3 adenosine receptor agonist protects against doxorubicin-induced cardiotoxicity.

Item

http://www.wikidata.org/entity/Q53779876

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Selective A3 adenosine recepto ...... ubicin-induced cardiotoxicity.

@en

Selective A3 adenosine recepto ...... ubicin-induced cardiotoxicity.

@nl

type

Item

label

Selective A3 adenosine recepto ...... ubicin-induced cardiotoxicity.

@en

Selective A3 adenosine recepto ...... ubicin-induced cardiotoxicity.

@nl

prefLabel

Selective A3 adenosine recepto ...... ubicin-induced cardiotoxicity.

@en

Selective A3 adenosine recepto ...... ubicin-induced cardiotoxicity.

@nl

P1476

Selective A3 adenosine recepto ...... ubicin-induced cardiotoxicity.

@en

P2093

Aya Galal

http://www.w3.org/2001/XMLSchema#string

Ebtehal El-Demerdash

http://www.w3.org/2001/XMLSchema#string

Ekram Nemr Abd Al Haleem

http://www.w3.org/2001/XMLSchema#string

Wesam M El-Bakly

http://www.w3.org/2001/XMLSchema#string

P2860

The A3 adenosine receptor agonist CP-532,903 [N6-(2,5-dichlorobenzyl)-3'-aminoadenosine-5'-N-methylcarboxamide] protects against myocardial ischemia/reperfusion injury via the sarcolemmal ATP-sensitive potassium channel

The PI3K-NF-kappaB signal transduction pathway is involved in mediating the anti-inflammatory effect of IB-MECA in adjuvant-induced arthritis

Comparison of the protective effects of amifostine and dexrazoxane against the toxicity of doxorubicin in spontaneously hypertensive rats

Disruption of the A(3) adenosine receptor gene in mice and its effect on stimulated inflammatory cells

Cardiomyocyte death in doxorubicin-induced cardiotoxicity

Expression and functional role of adenosine receptors in regulating inflammatory responses in human synoviocytes.

Novel N6-substituted adenosine 5'-N-methyluronamides with high selectivity for human adenosine A3 receptors reduce ischemic myocardial injury.

Failure of CGS15943A to block the hypotensive action of agonists acting at the adenosine A3 receptor.

A3 adenosine receptor agonist reduces brain ischemic injury and inhibits inflammatory cell migration in rats.

Pharmacological and therapeutic effects of A3 adenosine receptor agonists

P2888

s00280-015-2937-y

P304

309-322

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00280-015-2937-Y

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-12-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26676227

http://www.w3.org/2001/XMLSchema#string

Selective A3 adenosine receptor agonist protects against doxorubicin-induced cardiotoxicity.

about

P2860

P2860

Selective A3 adenosine receptor agonist protects against doxorubicin-induced cardiotoxicity.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P698